Latest News

People have long been willing to pay for healthcare despite rising costs, with Medtronic and Eli Lilly offering two different angles on the space.

Rocket Pharmaceuticals (NASDAQ:RCKT) outlined updated clinical, regulatory and commercial plans for its investigational gene therapy RP-A501 in Danon disease, reporting longer-term Phase I findings, preliminary Phase II observations and an FDA-aligned pivotal study design. Chief Executive Officer G

Nvidia just hit another record. It's closing in on $6 trillion.

AGCO (NYSE:AGCO) used its 2026 Technology Event to outline a long-term strategy centered on precision agriculture, mixed-fleet technology, data platforms and service delivered directly to farms. Chairman, President and Chief Executive Officer Eric Hansotia said the company remains fundamentally a m

Novo Nordisk has a huge opportunity in GLP-1 weight-loss drugs, but it has to prove it can use that success to build for the future.

Consumers are making up for lost travel time.

A TFSA yielding 6% would need roughly $200,000 to produce $1,000 in average monthly income.

Competition is increasing for DraftKings.

The company announced a splashy new AI cloud contract with an unnamed client.

Demand for energy is soaring, and that's great news for Bloom Energy.

Applied Materials held steady for most of two years before accelerating, while Nvidia's revenue nearly tripled over the same span.

Penguin Solutions (NASDAQ:PENG) reported record fourth-quarter results for fiscal 2026, driven by rising demand for AI infrastructure and data-center memory products, while raising its fiscal 2027 outlook for revenue and earnings. Fourth-quarter net sales rose 68% year over year to $567 million, wh

The computers may be futuristic. Getting paid for supplying their electricity is pleasantly old-fashioned.

Its upcoming industry conference is going to be a barn-burner.

Insider purchased shares at $17.98 each, well above the $3.43 market close on transaction date, signaling confidence despite recent valuation disconnect.

Picking winners and losers in the artificial intelligence industry hasn't been easy.

Two analysts raised their price targets on the electronic components maker.

Insider purchased shares through his revocable trust following a 19% stock decline over the past year, doubling his indirect holdings to 20,000 shares.

Neogen (NASDAQ:NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition. Chief Executive Officer Mi

Rezolve AI (NASDAQ:RZLV) outlined its strategy to build an end-to-end infrastructure platform for “agentic commerce,” reporting sharp first-half revenue growth and setting a target of at least $500 million in annual recurring revenue as it exits 2026. During an investor presentation, the company sa

Tariffs are raising costs across Canada, making the ability to protect margins increasingly valuable.

An analyst feels it's currently the No. 1 stock in its field.

Intuitive Machines bets on lunar dominance with 78% revenue concentration, while Redwire spreads risk across defense and commercial sectors, but both burn cash at scale.

A federal jury rejected all of Joby's counterarguments.

Claiming Social Security at 62 versus 70 creates a dramatic income gap that compounds over your retirement years.